This site contains promotional information intended only for healthcare professionals resident in the United Kingdom

Visit Pfizer Medical site
Search

Menu

Close

Sign In or RegisterLog Out
Pfizer MedicinesTherapy AreasExplore ContentEventsVideosMaterialsFeatured ArticlesLet’s ConnectSupplyAlliance HealthcareOff-contract claims

Example content

Adverse event reporting can be found at the bottom of the page

Comprehensive Migraine Management: Integrating Innovative Therapies

Prescribing information can be found at the bottom of the page.


Join us on 17 July 2024 to hear from Prof. Manjit Matharu, Professor of Neurology at University College London (UCL) discussing 'Comprehensive Migraine Management: Integrating Innovative Therapies' followed by a live interactive Q&A.

This promotional meeting is organised and funded by Pfizer Ltd for UK HCPs and may include reference to medicines or vaccines promoted by Pfizer. 
 

Prescribing information can be found at the bottom of the page.


Join us on 17 July 2024 to hear from Prof. Manjit Matharu, Professor of Neurology at University College London (UCL) discussing 'Comprehensive Migraine Management: Integrating Innovative Therapies' followed by a live interactive Q&A.

This promotional meeting is organised and funded by Pfizer Ltd for UK HCPs and may include reference to medicines or vaccines promoted by Pfizer. 
 

Event Date17 July 2024 12:55 BSTDuration1 Hr AudienceConsultants, General practitioners, Nurses, Pharmacists, Specialist Registrars {{givenName}}%20{{familyName}}%20has%20shared%20a%20resource%20with%20you%3B%20please%20click%20the%20link%20below%3A%0D%0A%0D%0A{{URL}}%0D%0A%0D%0AThank%20you%2C%0D%0A{{givenName}}%20{{familyName}}
Agenda
Meeting Agenda 12:45 - 12:55Joining & Registration
12:55 - 13:00Welcome and Introduction Ushma Patel, Pfizer Ltd
13:00 - 13:45Comprehensive Migraine Management: Integrating Innovative Therapies Manjit Matharu - Professor
13:45 - 14:00Questions & Answers Manjit Matharu - Professor
14:00Meeting Closes
Speakers
Event Speakers
Manjit Matharu, Professor
Manjit Matharu, ProfessorProfessor of Neurology at University College London (UCL), The National Hospital for Neurology and Neurosurgery

Prof Matharu trained at The University of Manchester and completed his general medical training in London leading up to obtaining the MRCP in 1998. He subsequently obtained a PhD at The UCL Institute of Neurology, Queen Square, London. He completed his residency in Neurology at The National Hospital for Neurology and Neurosurgery, The Royal London Hospital and Homerton Hospital in London in 2007 before taking up his current post. Prof Matharu is a member of the Headache and Pain subcommittee of the Association of British Neurologists. He was a member of the National Institute for Health and Clinical Excellence (NICE) guideline development group (GDG) for Headache Disorders.

Vydura®(rimegepant) 

Prescribing Information

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Pfizer Medical Information on 01304 616161.

PP-NNT-GBR-1833. May 2024

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search 

for MHRA Yellow Card in Google Play or Apple App Store

 

Adverse events should also be reported to Pfizer Medical Information on 01304 616161

PfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign In or RegisterAccountSign Out

This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc

 

This website is brought to you by Pfizer Limited, a company registered in England 

and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ

 

Copyright © 2024 Pfizer Limited. All rights reserved.

 

VAT registration number GB201048427

PP-UNP-GBR-7866. January 2024
For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-UNP-GBR-7812. January 2024

YesNo
You are now leaving PfizerPro​​​​​

​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site.​​​​​​​​​​​​​​

​​​​​​​PP-PFE-GBR-3858. November 2021​​​​​​​
​​​​​​​
You are now leaving PfizerPro
​​​​​​​
​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site other than the information or other materials relating to ​​​​​Pfizer medicines or 
business which it has provided or reviewed.

PP-PFE-GBR-3859. November 2021
​​​​​​​